|
Prevalence of cutaneous manifestations in chronic renal failure
patients on regular hemodialysis: a hospital-based study
|
|
|
The effect of narrow-band ultraviolet-B phototherapy on soluble
intercellular adhesion molecule-1 and soluble E-selectin in
psoriasis vulgaris patients
|
|
|
SERUM LEVEL OF INTERLUKIN -17 AND ITS GENE EXPRESSION IN THE SKIN OF PATIENTS WITH VITILIGO
|
|
|
EVALUATION OF RESPONSE OF PSORIASIS TO NARROW-BAND ULTRAVIOLET B WITH PREIRRADITION USE OF MINERAL OIL
|
|
|
FEMALE SEXUAL DYSFUNCTION ACROSS THE THREE PREGNANCY TRIMESTERS: AN EGYPTIAN STUDY
|
|
|
FREQANCY OF POLYCYSTIC OVARIAN SYNDROME IN WOMEN WITH POST-ADOLESCENT ACNE
|
|
|
OXIDATIVE STRESS IN THE BLOOD OF PATIENTS WITH ACTIVE LOCALIZED VITILIGO
|
|
|
Microneedling System Alone versus Microneedling System with
Trichloroacetic Acid in the Management of Abdominal Striae
Rubra: a clinical and histopathological study
|
|
|
Salicylic-Mandelic Acid versus Glycolic Acid Peels in Egyptian Patients with Acne Vulgaris
|
|
|
Skin manifestations in Egyptian diabetic patients: a case
series study
|
|
|
Intralesional Injection of 5-Fluorouracil versus Bleomycin in Treatment of Periungual and Plantar Warts
|
|
|
Intralesional injection of 5-Fluorouracil alone or combined with Triamcinolone acetonide versus Bleomycin in treatment of Keloids
|
|
|
Role of Erythroid Differentiation Regulator 1 (Erdr1) in Alopecia Areata
|
|
Angiotensin‐converting enzyme gene insertion/deletion polymorphism and family history in severe acne vulgaris
|
|
evaluation of serum levels of neurotrophin 4
and brain-derived nerve growth factor in uremic pruritus patients
|
|
Assessment of macrophage migration inhibitory factor in patients with verruca vulgaris
|
|
Novel marker in proliferative and involuting phases of infantile hemangioma
|
|
Prognostic markers for severity, activity, and recurrence of alopecia areata
|
|
Intralesional injection of bevacizumab versus triamcinolone acetonide in infantile hemangioma
|
|
|
intralesional injection of vitamin D in verruca vulgaris increases cathelicidin (LL37) expression; therapeutic and immunohistochemical study
|
|